Sandra Van Schaeybroeck

Belfast, NIR, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

My Himalayan Health Experience.

My Himalayan Health Experience.

Journal: The Ulster medical journal

Published: May 02, 2025

Women at the Heart of Tribal Healthcare: A Reflection from a Rural Medical Elective in Southern India.

Women at the Heart of Tribal Healthcare: A Reflection from a Rural Medical Elective in Southern India.

Journal: The Ulster medical journal

Published: May 02, 2025

A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC).

A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC).

Journal: BMC cancer

Published: February 11, 2025

A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers.

A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers.

Journal: BJC reports

Published: February 08, 2025

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.

Journal: ESMO open

Published: May 23, 2024

Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.

Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.

Journal: Nature metabolism

Published: March 27, 2024

Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.

Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.

Journal: Molecular cancer research : MCR

Published: February 06, 2024

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer.

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer.

Journal: Molecular cancer therapeutics

Published: April 29, 2022

Orthogonal MET analysis in a population-representative stage II-III colon cancer cohort: prognostic and potential therapeutic implications.

Orthogonal MET analysis in a population-representative stage II-III colon cancer cohort: prognostic and potential therapeutic implications.

Journal: Molecular oncology

Published: August 03, 2021

An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolution.

An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolution.

Journal: Cell death and differentiation

Published: May 27, 2021

FLINO: a new method for immunofluorescence bioimage normalization.

FLINO: a new method for immunofluorescence bioimage normalization.

Journal: Bioinformatics (Oxford, England)

Published: May 13, 2021

Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations.

Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 16, 2021

Showing 1-12 of 52

Last Updated: 09/26/2026